Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

导出原文传递

翻译打印收藏纠错

第一作者： P,Baliakas

第一单位： Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

作者： P,Baliakas ^[1] ; M,Mattsson ^[2] ; K,Stamatopoulos ^[3] ; R,Rosenquist ^[1]

作者单位： Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. ^[1] Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.;Department of Medical Sciences, Uppsala University, Uppsala, Sweden. ^[2] Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.;Institute of Applied Biosciences, Center of Research and Technology Hellas Center of Research and Technology Hellas (CERTH), Thessaloniki, Greece. ^[3]

关键词 CLL decision points patient management predictive markers prognostic index

主题词决策支持技术(Decision Support Techniques);基因, p53(Genes, p53);人类(Humans);白血病, 淋巴样(Leukemia, Lymphoid);突变(Mutation);预后(Prognosis)

DOI 10.1111/joim.12455

PMID 26709197

发布时间 2016-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交